It’s wild to think that a math puzzle from the 1200s is now helping power AI, encryption, and the digital world we live in.

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and currently holds a Life, Accident, and Health License in Indiana. He has 8 years experience in finance, from ...

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Yarilet Perez is an experienced multimedia journalist and fact-checker with a ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Australia captain Harry Wilson accuses England of 'whinging' after report reveals Steve Borthwick raised potential illegal Wallabies breakdown tactics this week to referee; England get Autumn Nation ...

No more Galaxy S25 flagships will use Exynos chips, according to numerous sources. European, Austrailian, and other international users are celebrating the end of Exynos era. The pro-Snapdragon rumors ...